|
CDSCO cancels registration of cosmetic products importer
|
|
Gireesh Babu, New Delhi
September 04 , 2026
|
|
|
The Central Drugs Standard Control Organisation (CDSCO) has cancelled registration certificates of Delhi-based Skintl Enterprises to import cosmetics products after identifying various violations including sales of unregistered products through e-commerce platforms.
The Cosmetics Division of the CDSCO, in an order, said that it conducted an investigation at the premises of the company on March 30, 2026, in connection with a complaint regarding sale of cosmetic products through various e-commerce platforms and their own retail outlets.
The company had three registrations for import of cosmetic products, one valid till October 24, 2029, another till December 16, 2030, and yet another one till November 17, 2025.
The CDSCO, while cancelling these registration certificates based on various Sections and Rules under the Drugs and Cosmetics Act, 1940 and the Cosmetics Rules, 2020, said that the firm was found to have mentioned incorrect registration certificate numbers on product labels, and multiple products were found stocked without valid registration certificates.
"Further, it was observed that the firm had shifted its warehouse premises without prior intimation or approval from the licensing authority. ln addition to the above, several other deficiencies and non-compliances were also reported by the joint investigation team in investigation report dated 09.04.2026," said the drugs regulator.
As per the Drug & Cosmetics Act, 1940, no person shall import any misbranded drug, and misbranded or spurious cosmetic. Cosmetics Rules, 2020, stipulates that no cosmetic shall be imported into the country unless the product has been registered in accordance with these rules by the Central Licensing Authority.
The rules also state that in case of change in name or address of a registration holder or overseas manufacturer, after grant of registration under Sub-rule (1) of Rule 13, an application for amendment shall be made in online portal of Central government for prior approval from the central Licensing Authority for the said changes in registration certificate within a period of sixty days from the date of such change.
Besides, the rules also stipulate that no person shall alter, obliterate or deface any inscription or mark made or recorded by the manufacturer on the container, label or wrapper of any cosmetic. The registration certificate also mandates that the manufacturer or importer shall inform any change in labelling, composition or testing of the product with the licensing authority within thirty days in writing, along with an undertaking that the products comply with the standards laid down by the Bureau of Indian Standards.
The CDSCO issued a show cause notice on April 27, 2026, and said that the firm has submitted its response dated June 30, 2026, acknowledging the violations observed by the regulator.
As reported earlier, in a matter of heightened vigilance against imports and distribution of unapproved cosmetics in the domestic market, the CDSCO in July, this year, asked its zonal offices and the State Licensing Authorities (SLAs) across the country to enhance surveillance on such cosmetic products.
Dr Rajeev Singh Raghuvanshi, Drugs Controller General (India), during the time said that it has come to the CDSCO's notice that imported cosmetics are being sold in the domestic market without a valid registration certificate.
"Accordingly, SLAs & zonal heads of CDSCO are requested to direct the inspectorate under their control for enhanced surveillance on such cosmetics products," said the DCGI.
The central drug regulator also directed all port officers to keep a strict vigil on such activities to curb entry of cosmetics in India without a registration certificate.
In May, it requested the public to report any violation they observe in the segment in the country to the Central or state regulatory authorities, following a couple of actions taken by the CDSCO's Cosmetics Division against importers for allegedly misleading the consumer through labels, and filing fabricated documents, among others.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|